Dreams Come True: Breast Cancers Eliminated by Vaccine

SHIRLEY, N.Y. - Jan. 22, 2020 - PRLog -- It is reported that there are an estimated 18.19 million new cancer cases and 9.6 million cancer deaths worldwide up to 2018. Although a wide variety of treatments or health products have emerged in an endless stream every year to treat or prevent cancers, few medicines are proved efficient to cure cancers. Surprisingly, a new cancer vaccine was successfully developed, by which the tumors in patients' body has completely disappeared.

What is a cancer vaccine?

Cancer vaccine is one of the latest treatments in cancer immunotherapy, which can identify the proteins present on specific cancer cells, prevent cancer cells from growing and recurring, and eventually remove cancer cells remaining after treatment.

Unlike chemotherapy and radiotherapy, which directly kill tumor cells and normal fast-dividing cells in the body, cancer vaccines work by stimulating the body's immune system to specifically targets tumor cells, thereby reducing the occurrence of side effects. In light of these characteristics, cancer vaccine (https://www.creative-biolabs.com/vaccine/cancer-vaccines.htm) provides patients with a more targeted and gentler approach to cancer treatment, which is much less harmful to the body and enables a more comfortable daily life.

A successful anti-cancer treatment never comes easy, especially when a complete remission is expected. Recently, a novel cancer vaccine developed by Mayo Clinic has proved able to clean all cancer cells of a patient with breast cancer, which is in clinic trials. This lucky dog, who comes from Florida, was extremely astonished when diagnosed with breast cancer since she considered herself a fitness fanatic. She has insisted on living a healthy and regular life in the past years. However, the physical examination finally pointed out that she had stage 0 breast cancer.

At that moment, there were three ways for her: tumor resection, mastectomy, or a cancer vaccine clinical trail. As is known, she participated in the 12-week clinical trial. The vaccine was injected three times in succession with two arms in rotation, four times in total, two weeks apart. The vaccine fights cancer cells in the body by stimulating the patient's own immune response, thereby completely eradicating those cancer cells. As a consequence, if the immune system is trained to recognize cancer cells or precancerous cells, maybe it can eliminate precancerous cells even before they develop into cancer cells.

At present, the vaccine has been successfully prepared in stock. Patients can directly get a cancer vaccination as same as a pneumonia vaccination. Meanwhile, two new cancer patients are trying this treatment, in hope of a complete remission. Researchers revealed that the vaccine will begin phase I, II, and III clinical studies in 2020. It will be approved by the FDA for marketing within 8 years and will be available to the general public through hospitals and pharmacies.